Salivary Biomarkers in Alzheimer´s Disease

par Santos,Gustavo A. A, Olave,Enrique, Pardi,Paulo C
Publié 2020

Association of a Total Cholesterol Polygenic Score with Cholesterol Levels and Pathological Biomarkers across the Alzheimer’s Disease Spectrum

par Nathalie I. V. Nilsson, Cynthia Picard, Anne Labonté, Theresa Köbe, Pierre-François Meyer, Sylvia Villeneuve, Daniel Auld, Judes Poirier, for the PREVENT-AD Research Group, Alzheimer’s Disease Neuroimaging Initiative
Publié 2021

Minocycline alleviates beta-amyloid protein and tau pathology via restraining neuroinflammation induced by diabetic metabolic disorder

par Cai Z, Yan Y, Wang Y
Publié 2013

Peptide-Based Vaccines for Neurodegenerative Diseases: Recent Endeavors and Future Perspectives

par Vyronia Vassilakopoulou, Chrysoula-Evangelia Karachaliou, Alexandra Evangelou, Christos Zikos, Evangelia Livaniou
Publié 2021

Erratum: Behavioral Abnormalities in Knockout and Humanized Tau Mice

par Frontiers Production Office
Publié 2021

Tauopathy and cognitive impairment in experimental diabetes mellitus

par Mariia V. Matveeva, Yulia G. SamoiIova, Natalia G. Zhukova, Oksana A. Oleynik, Maria A. Rotkank
Publié 2017

Attenuative Effects of Fluoxetine and <i>Triticum aestivum</i> against Aluminum-Induced Alzheimer’s Disease in Rats: The Possible Consequences on Hepatotoxicity and Nephrotoxicity...

par Karema Abu-Elfotuh, Ghada M. Ragab, Ahmad Salahuddin, Lubna Jamil, Ekram Nemr Abd Al Haleem
Publié 2021

Clioquinol Decreases Levels of Phosphorylated, Truncated, and Oligomerized Tau Protein

par Gaoping Lin, Feiyan Zhu, Nicholas M. Kanaan, Rei Asano, Norimichi Shirafuji, Hirohito Sasaki, Tomohisa Yamaguchi, Soichi Enomoto, Yoshinori Endo, Asako Ueno, Masamichi Ikawa, Kouji Hayashi, Osamu Yamamura, Shu-Hui Yen, Yasunari Nakamoto, Tadanori Hamano
Publié 2021

Detection of hyperphosphorylated tau protein and &alpha;-synuclein in spinal cord of patients with Alzheimer&rsquo;s disease

par Guo YJ, Wang LN, Zhu MW, Zhang HH, Hu YZ, Han ZT, Liu J, Zhao WQ, Wang DX
Publié 2016

Alzheimer&#39;s disease and blood-based biomarkers &ndash; potential contexts of use

par Zvěřová M
Publié 2018

All roads lead to Rome — a review of the potential mechanisms by which exerkines exhibit neuroprotective effects in Alzheimer’s disease

par Yi-Yao Liang, Li-Dan Zhang, Xi Luo, Li-Li Wu, Zhao-Wei Chen, Guang-Hao Wei, Kai-Qing Zhang, Ze-An Du, Ren-Zhi Li, Kwok-Fai So, Ang Li
Publié 2022

The molecular mechanisms of signal pathway activating effect of E2F-1/NF-κB/GSK-3β on cognitive dysfunction of Alzheimer rats

par Mayila Tuerxun, Ajar Muhda, Lixin Yin
Publié 2021

Higher Plasma APOC-III Was Associated with a Slower Reduction of &beta;-Amyloid Levels in Cerebrospinal Fluid Among Older Individuals Without Dementia

par Zhang X
Publié 2020

Clinical and analytical comparison of six Simoa assays for plasma P-tau isoforms P-tau181, P-tau217, and P-tau231

par Sherif Bayoumy, Inge M. W. Verberk, Ben den Dulk, Zulaiga Hussainali, Marissa Zwan, Wiesje M. van der Flier, Nicholas J. Ashton, Henrik Zetterberg, Kaj Blennow, Jeroen Vanbrabant, Erik Stoops, Eugeen Vanmechelen, Jeffrey L. Dage, Charlotte E. Teunissen
Publié 2021